Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial

Post time Half hour(s) ago

Zifeng Yang, Yangqing Zhan, Zhengtu Li, Zhengshi Lin, Zhonghao Fang, Haijun Li, Xiaolin Chen, Banghan Ding, Huiqing Zeng, Xiuwei Zhang, Yudi Song, Zejun Lin, Shiwei Liang, Jincan Luo, Jufang Huang, Xiaoxin Chen, Nanshan Zhong, Shuyue Xia, Gangfu Ye, Jie Peng, Xiaoguang Li, Xiaowei Xu, Lihong Qu, Xifu Wang, Ping Zhang, Zhijun Su, Zhen Tao, Min Pan, Hui Yang, Yingyun Fu, Yu Zhang, Hua Qiao, Limin Dong, Xiaoju Zhang, Ping Feng, Lei Shao, Xiansheng Liu,
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial,
The Lancet Respiratory Medicine,
Volume 13, Issue 7,
2025,
Pages 597-610,
ISSN 2213-2600,https://doi.org/10.1016/S2213-2600(25)00046-3

https://pubmed.ncbi.nlm.nih.gov/40489986/

[Other] Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial